JANX - Janux Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - JANX (1817713)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
19 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-12-03
JANXCampbell David AlanPres, CEOS - Sale$67.00-15,000242,054-6%-$1,005,000
2024-11-25
JANXCampbell David AlanPres, CEOS - Sale$51.60-25,000257,054-9%-$1,289,879
2024-10-28
JANXCampbell David AlanPres, CEOS - Sale$53.54-25,000282,054-8%-$1,338,559
D
2024-09-13
JANXLichter Jay10%S - Sale+OE$46.68-3,8156,560,8160%-$178,084
2024-10-18
JANXRa Capital Management, L.P.Dir, 10%P - Purchase$44.75+1,200,00010,365,652+13%+$53,700,000
DM
2024-10-16
JANXAvalon Ventures Xi, L.P.10%S - Sale+OE$46.30-1,673,1287,377,765-18%-$77,472,371
DM
2024-09-26
JANXAvalon Ventures Xi, L.P.10%S - Sale+OE$46.96-307,7796,363,452-5%-$14,452,394
D
2024-09-27
JANXMeyer Andrew HollmanChief Business OfficerS - Sale+OE$45.96-50,00067,592-43%-$2,297,755
2024-09-27
JANXDiraimondo ThomasChief Scientific OfficerS - Sale$46.34-5,00097,938-5%-$231,716
2024-09-27
JANXCampbell David AlanPres, CEOS - Sale$46.31-25,000307,054-8%-$1,157,641
M
2024-09-10
JANXAvalon Ventures Xi, L.P.10%S - Sale$46.89-451,0919,778,633-4%-$21,153,619
DM
2024-09-06
JANXAvalon Ventures Xi, L.P.10%S - Sale+OE$42.00-242,1823,849,056-6%-$10,172,364
2024-06-03
JANXLichter JayDir, 10%S - Sale$54.75-1,500,0007,249,490-17%-$82,125,000
2024-06-03
JANXReardon TigheActing CFOS - Sale$54.75-822,7214,148,680-17%-$45,043,975
2024-06-03
JANXAvalon Ventures Xi, L.P.10%S - Sale$54.75-1,500,0007,244,907-17%-$82,125,000
2023-11-13
JANXReardon TigheActing CFO, 10%P - Purchase$5.87+849,8545,329,346+19%+$4,988,643
2023-11-13
JANXLichter JayDir, 10%P - Purchase$5.87+849,8549,716,563+10%+$4,988,643
2023-11-13
JANXAvalon Ventures Xi, L.P.10%P - Purchase$5.87+849,8549,716,563+10%+$4,988,643
D
2023-07-19
JANXRa Capital Management, L.P.Dir, 10%P - Purchase$12.46+495,0089,165,652+6%+$6,167,800

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top